GuiZhou SanLi Pharmaceutical Co.,Ltd

SSE:603439.SS

12.16 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013
Revenue 2,144.3861,634.9781,201.316938.966630.225883.783722.346638.331514.609359.042266.878159.326
Cost of Revenue 649.987436.311339.505277.007208.979298.756249.774214.017179.915135.647101.49360.72
Gross Profit 1,494.3991,198.667861.812661.959421.246585.027472.572424.314334.694223.395165.38598.606
Gross Profit Ratio 0.6970.7330.7170.7050.6680.6620.6540.6650.650.6220.620.619
Reseach & Development Expenses 46.50430.61117.8637.6815.6313.5116.8635.45.6220.6890.1330.037
General & Administrative Expenses 35.85527.98720.70816.1349.9546.5768.503-1.6533.7394.2684.272.972
Selling & Marketing Expenses 761.62794.46562.622450.837276.751393.942337.182302.615238.442156.962120.35769.826
SG&A 797.476820.672583.33466.972286.705400.518345.685300.962242.181161.23124.62672.799
Other Expenses 324.17111.55536.62224.28520.91526.22130.36315.64220.6610.4311.7447.008
Operating Expenses 1,168.15862.838637.815498.938313.251430.249373.1336.451264.729172.473132.77878.191
Operating Income 326.249335.829225.549179.192112.27154.59699.77787.5366.61350.83432.24616.808
Operating Income Ratio 0.1520.2050.1880.1910.1780.1750.1380.1370.1290.1420.1210.105
Total Other Income Expenses Net -1.223-1.806-2.99-2.542-2.3731.19830.36315.91820.6610.4311.7395.859
Income Before Tax 325.025334.022222.559176.65109.897155.794130.14103.44887.27361.26533.98522.667
Income Before Tax Ratio 0.1520.2040.1850.1880.1740.1760.180.1620.170.1710.1270.142
Income Tax Expense 45.18839.15330.62128.04915.94622.72519.65915.8212.3938.6544.993.294
Net Income 274.028292.703201.284152.28393.953133.082110.48387.62874.8852.6128.99419.373
Net Income Ratio 0.1280.1790.1680.1620.1490.1510.1530.1370.1460.1470.1090.122
EPS 0.670.710.490.370.230.330.30.240.220.170.0940.063
EPS Diluted 0.670.710.490.370.230.330.30.240.220.170.0940.063
EBITDA 415.411369.183243.993191.582112.979159.722138.02195.19991.10163.59334.74519.843
EBITDA Ratio 0.1940.2260.2030.2040.1790.1810.1910.1490.1770.1770.130.125